(Q34779138)

English

Assessing the efficacy of targeted therapy using circulating epithelial tumor cells (CETC): the example of SERM therapy monitoring as a unique tool to individualize therapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 August 2017

Assessing the efficacy of targeted therapy using circulating epithelial tumor cells (CETC): the example of SERM therapy monitoring as a unique tool to individualize therapy (English)

1 reference

Europe PubMed Central

4 August 2017

author name string

Katharina Pachmann

1

1 reference

Europe PubMed Central

4 August 2017

Oumar Camara

2

1 reference

Europe PubMed Central

4 August 2017

Annika Kohlhase

3

1 reference

Europe PubMed Central

4 August 2017

Carola Rabenstein

4

1 reference

Europe PubMed Central

4 August 2017

Torsten Kroll

5

1 reference

Europe PubMed Central

4 August 2017

Ingo B Runnebaum

6

1 reference

Europe PubMed Central

4 August 2017

Klaus Hoeffken

7

1 reference

Europe PubMed Central

4 August 2017

publication date

8 August 2010

1 reference

Europe PubMed Central

4 August 2017

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

4 August 2017

137

1 reference

Europe PubMed Central

4 August 2017

5

1 reference

Europe PubMed Central

4 August 2017

821-828

1 reference

Europe PubMed Central

4 August 2017

https://scigraph.springernature.com/pub.10.1007/s00432-010-0942-4

0 references

All circulating EpCAM+CK+CD45- objects predict overall survival in castration-resistant prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074080

7 July 2018

Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074080

7 July 2018

Impact of the duration of adjuvant hormonal therapy in patients with locally advanced prostate cancer treated with radiotherapy: a secondary analysis of RTOG 85-31.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074080

7 July 2018

Recent advances in metastasis research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074080

7 July 2018

Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: intention-to-treat analysis of the National Surgical Adjuvant Breast And Bowel Project B-33 trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074080

7 July 2018

Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074080

7 July 2018

A review of the BIG results: the Breast International Group 1-98 trial analyses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074080

7 July 2018

Efficacy of adjuvant chemotherapy according to hormone receptor status in young patients with breast cancer: a pooled analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074080

7 July 2018

Controversies of adjuvant endocrine treatment for breast cancer and recommendations of the 2007 St Gallen conference.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074080

7 July 2018

Hormonal therapies for early breast cancer: systematic review and economic evaluation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074080

7 July 2018

Seeding of epithelial cells into circulation during surgery for breast cancer: the fate of malignant and benign mobilized cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074080

7 July 2018

Controversies in the therapy of early stage breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074080

7 July 2018

Maintenance therapy to suppress micrometastasis: the new challenge for adjuvant cancer treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074080

7 July 2018

Standardized quantification of circulating peripheral tumor cells from lung and breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074080

7 July 2018

30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074080

7 July 2018

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074080

7 July 2018

Annual hazard rates of recurrence for breast cancer after primary therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074080

7 July 2018

Meta-analysis of adjuvant medical treatment in breast cancers. Ten year results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074080

7 July 2018

Tamoxifen: a review of its pharmacological properties and therapeutic use in the treatment of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074080

7 July 2018

Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0942-4

21 January 2018

Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor--positive breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0942-4

21 January 2018

The 38th David A. Karnofsky lecture: the paradoxical actions of estrogen in breast cancer--survival or death?

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0942-4

21 January 2018

Moving research from bench to bedside to community: there is still more to do.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0942-4

21 January 2018

Clinical significance of CYP2D6 polymorphisms and tamoxifen in women with breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074080

26 October 2018

Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074080

26 October 2018

The relevance of circulating epithelial tumor cells (CETC) for therapy monitoring during neoadjuvant (primary systemic) chemotherapy in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0942-4

21 January 2018

Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trial

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0942-4

21 January 2018

Quantification of circulating tumour cells for the monitoring of adjuvant therapy in breast cancer: An increase in cell number at completion of therapy is a predictor of early relapse

1 reference

https://pubmed.ncbi.nlm.nih.gov/20694797

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Adjuvant chemotherapy of breast cancer: an international review and the Swiss experience]

1 reference

https://pubmed.ncbi.nlm.nih.gov/20694797

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved overall survival in postmenopausal women with early breast cancer after anastrozole initiated after treatment with tamoxifen compared with continued tamoxifen: the ARNO 95 Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20694797

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tamoxifen in the treatment of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20694797

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Longtime recirculating tumor cells in breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20694797

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating tumor cells in patients with breast cancer dormancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20694797

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of unseparated human lymphocytes by flow cytometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/20694797

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00432-010-0942-4

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34779138&oldid=1955536054"